6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-06-09), Lexeo Therapeutics's 6-1 Month Momentum % is 3.31%.
The industry rank for Lexeo Therapeutics's 6-1 Month Momentum % or its related term are showing as below:
LXEO's 6-1 Month Momentum % is ranked better than 58.23% of 1525
companies
in the Biotechnology industry
Industry Median: -5.06
vs LXEO: 3.31
Competitive Comparison of Lexeo Therapeutics's 6-1 Month Momentum %
For the Biotechnology subindustry, Lexeo Therapeutics's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lexeo Therapeutics's 6-1 Month Momentum % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Lexeo Therapeutics's 6-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Lexeo Therapeutics's 6-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Lexeo Therapeutics 6-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Lexeo Therapeutics's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Lexeo Therapeutics (Lexeo Therapeutics) Business Description
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LXEO has been successfully added to your